50% effective concentration of sevoflurane for immobility in cerebral palsy children undergoing botulinum toxin

Kanghui Kim1, Eunhee Lee, Sung Mee Jung

  • 1Department of Anesthesiology and Pain Medicine, Yeungnam University College of Medicine, Daegu, Republic of Korea.

Medicine
|October 25, 2022
PubMed

Insights

The optimal end-tidal sevoflurane concentration for immobile botulinum toxin injections in children with cerebral palsy (CP) is 1.76%. This concentration ensures successful procedures in 50% of pediatric patients undergoing treatment.

Area of Science:

  • Anesthesiology
  • Pediatric Medicine
  • Neurology

Background:

  • Cerebral palsy (CP) affects children's motor functions, often necessitating treatments like botulinum toxin injections.
  • Immobility is crucial for the success of botulinum toxin injections, especially in pediatric patients.

Purpose of the Study:

  • To determine the optimal end-tidal sevoflurane concentration for achieving immobility during botulinum toxin injections.
  • To establish the effective concentration (EC50) of sevoflurane for this specific pediatric procedure.

Main Methods:

  • A prospective study involving 23 children (aged 3-12 years) with spastic CP.
  • Modified Dixon's up-and-down method was used to determine end-tidal sevoflurane concentration for immobility.
  • Botulinum toxin type A injections were administered to spontaneously breathing children under sevoflurane sedation.

Main Results:

  • The 50% effective end-tidal concentration (EC50) of sevoflurane for immobility was found to be 1.76% ± 0.15%.
  • Probit analysis predicted EC50 at 1.77% and the 95% effective concentration (EC95) at 2.09% for immobility.
  • 57.1% of the children achieved "no movement" during the injection at the determined concentrations.

Conclusions:

  • Botulinum toxin injections can be safely and effectively performed in spontaneously breathing children with CP using a specific sevoflurane concentration.
  • An end-tidal sevoflurane concentration of 1.76% ± 0.15% is effective for achieving immobility in 50% of pediatric patients with CP undergoing botulinum toxin injections.
Abstract

Related Concept Videos

Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
369
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
588
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
187
Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
740
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
450
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
437